Trial Profile
A Randomized, Placebo-Controlled, Double-Blind Study to Evaluate the Analgesic Efficacy, Safety and Tolerability of Intravenous N1539 in Subjects After Abdominal Laparoscopic Surgery
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 27 Feb 2019
Price :
$35
*
At a glance
- Drugs Meloxicam (Primary) ; Ketorolac
- Indications Postoperative pain
- Focus Therapeutic Use
- Sponsors Alkermes plc
- 20 Feb 2019 Results of a pooled analysis (NCT01436032, NCT00945763, NCT01084161, NCT02540265, NCT02678286, NCT02675907 and NCT02720692) was published online in Regional Anesthesia & Pain Medicine.
- 16 Apr 2018 According to a Recro Pharma media release, data from this trial will be presented at the 43rd Annual Regional Anesthesiology and Acute Pain Medicine Meeting co-hosted by the American Society of Regional Anesthesia and Pain Medicine (ASRA).
- 12 Mar 2012 Status changed from active, no longer recruiting to discontinued as reported by ClinicalTrials.gov.